Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Vaccaro · SciRah

Researcher profile · Semantic Scholar

N. Vaccaro

Share profile

N. Vaccaro — researcher profile on SciRah

h-index: 18
Works: 26
Citations: 1,056

Most-cited papers

Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion
D. Polidori, S. Sha, S. Mudaliar, T. Ciaraldi +5 more
2013Diabetes Care268 citations Open access
Semantic Scholar
Effects of JNJ‐38431055, a novel GPR119 receptor agonist, in randomized, double‐blind, placebo‐controlled studies in subjects with type 2 diabetes
L. B. Katz, J. Gambale, P. Rothenberg, S. Vanapalli +4 more
2012Diabetes, obesity and metabolism101 citations
Semantic Scholar
Pharmacokinetics and Pharmacodynamics of a Transdermal Contraceptive Patch and an Oral Contraceptive
D. Devineni, D. Skee, N. Vaccaro, J. Massarella +3 more
2007Journal of clinical pharmacology66 citations
Semantic Scholar
Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Rivaroxaban
K. Moore, A. Plotnikov, An Thyssen, N. Vaccaro +2 more
2011Journal of Cardiovascular Pharmacology61 citations
Semantic Scholar
Pharmacokinetics, Safety, and Tolerability of Doripenem After 0.5‐, 1‐, and 4‐Hour Infusions in Healthy Volunteers
I. Cirillo, N. Vaccaro, K. Turner, B. Solanki +2 more
2009Journal of clinical pharmacology54 citations
Semantic Scholar
Canagliflozin, a sodium glucose co-transporter 2 inhibitor, reduces post-meal glucose excursion in patients with type 2 diabetes by a non-renal mechanism: results of a randomized trial.
P. Stein, J. Berg, L. Morrow, D. Polidori +4 more
2014Metabolism: Clinical and Experimental52 citations Open access
Semantic Scholar
Effects of hydrochlorothiazide on the pharmacokinetics, pharmacodynamics, and tolerability of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants.
D. Devineni, N. Vaccaro, D. Polidori, S. Rusch +1 more
2014Clinical Therapeutics50 citations Open access
Semantic Scholar
Effect of hepatic or renal impairment on the pharmacokinetics of canagliflozin, a sodium glucose co-transporter 2 inhibitor.
D. Devineni, C. Curtin, T. Marbury, William B. Smith +6 more
2015Clinical Therapeutics48 citations
Semantic Scholar
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ‐38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects
L. B. Katz, J. Gambale, P. Rothenberg, S. Vanapalli +6 more
2011Clinical pharmacology and therapy48 citations
Semantic Scholar
Effects of rifampin, cyclosporine A, and probenecid on the pharmacokinetic profile of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants
D. Devineni, N. Vaccaro, J. Murphy, C. Curtin +8 more
2014International journal of clinical pharmacology and therapeutics46 citations Open access
Semantic Scholar
Disposition, Metabolism, and Excretion of [14C]Doripenem after a Single 500-Milligram Intravenous Infusion in Healthy Men
I. Cirillo, G. Mannens, C. Janssen, M. Vermeir +7 more
2008Antimicrobial Agents and Chemotherapy42 citations Open access
Semantic Scholar
Pharmacokinetic and pharmacodynamic profiles of extended dosing of epoetin alfa in anemic patients who have chronic kidney disease and are not on dialysis.
T. Mcgowan, N. Vaccaro, J. Beaver, J. Massarella +1 more
2008American Society of Nephrology. Clinical Journal30 citations Open access
Semantic Scholar
Impact on abiraterone pharmacokinetics and safety: Open‐label drug–drug interaction studies with ketoconazole and rifampicin
Apexa Bernard, N. Vaccaro, M. Acharya, J. Jiao +6 more
2015Clinical pharmacology in drug development29 citations
Semantic Scholar
Bioequivalence of Canagliflozin/Metformin Immediate Release Fixed-Dose Combination Tablets Compared with Concomitant Administration of Single Components of Canagliflozin and Metformin in Healthy Fed Participants
D. Devineni, C. Curtin, J. Ariyawansa, S. Weiner +6 more
201427 citations Open access
Semantic Scholar
Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Canagliflozin in Healthy Chinese Subjects.
Xia Chen, P. Hu, N. Vaccaro, D. Polidori +5 more
2015Clinical Therapeutics26 citations
Semantic Scholar
Influence of Continuous Venovenous Hemofiltration and Continuous Venovenous Hemodiafiltration on the Disposition of Doripenem
I. Cirillo, N. Vaccaro, D. Balis, Rebecca Redman +1 more
2011Antimicrobial Agents and Chemotherapy20 citations Open access
Semantic Scholar
Single- and multiple-dose pharmacokinetics and pharmacodynamics of canagliflozin, a selective inhibitor of sodium glucose co-transporter 2, in healthy participants.
D. Devineni, N. Vaccaro, D. Polidori, H. Stieltjes +1 more
2015International journal of clinical pharmacology and therapeutics19 citations
Semantic Scholar
Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on the pharmacokinetics of oral contraceptives, warfarin, and digoxin in healthy participants.
D. Devineni, Prasarn Manitpisitkul, N. Vaccaro, Apexa Bernard +7 more
2015International journal of clinical pharmacology and therapeutics18 citations
Semantic Scholar
Pharmacokinetics of abiraterone in healthy Japanese men: dose-proportionality and effect of food timing
K. Inoue, A. Shishido, N. Vaccaro, J. Jiao +4 more
2014Cancer Chemotherapy and Pharmacology17 citations
Semantic Scholar
Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological Age
I. Cirillo, N. Vaccaro, Bibiana Castañeda-Ruiz, Rebecca Redman +3 more
2015Antimicrobial Agents and Chemotherapy11 citations Open access
Semantic Scholar
Effect of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, on C‐peptide kinetics
D. Polidori, S. Sha, T. Heise, J. Natarajan +5 more
2015Clinical pharmacology in drug development7 citations
Semantic Scholar
Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy
Mahesh N. Samtani, N. Vaccaro, I. Cirillo, G. Matzke +2 more
2012ISRN Pharmacology7 citations Open access
Semantic Scholar
Pharmacokinetics of Single‐Dose Doripenem in Adults With Cystic Fibrosis
I. Cirillo, N. Vaccaro, Rebecca Redman, Philip L. Black +1 more
2012Journal of clinical pharmacology6 citations
Semantic Scholar
Pharmacokinetics Of Doripenem In Pediatric Patients With Cystic Fibrosis
N. Vaccaro, I. Cirillo, Rebecca Redman, P. Black +1 more
2011Asian Test Symposium3 citations
Semantic Scholar
To Evaluate the Single-Dose Pharmacokinetics , Safety , and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological
I. Cirillo, N. Vaccaro, Bibiana Castañeda-Ruiz, Rebecca Redman +3 more
20150 citations
Semantic Scholar
OP42 PHARMACODYNAMIC (PD) DIFFERENCES BETWEEN CANAGLIFLOZIN (CANA) 300 MG AND DAPAGLIFLOZIN (DAPA) 10 MG FOR URINARY GLUCOSE EXCRETION (UGE), RENAL THRESHOLD FOR GLUCOSE (RTG), AND POSTPRANDIAL PLASMA GLUCOSE (PPG) EXCURSION IN HEALTHY PARTICIPANTS
S. Sha, D. Polidori, Kristin Farrell, Atalanta Ghosh +5 more
20140 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Devineni×10
Invite
D. Devineni — researcher profile on SciRah
D. Polidori×8
Invite
D. Polidori — researcher profile on SciRah
I. Cirillo×8
Invite
I. Cirillo — researcher profile on SciRah
Rebecca Redman×8
Invite
Rebecca Redman — researcher profile on SciRah

×8

Invite

H. Stieltjes — researcher profile on SciRah

P. Rothenberg×7

Invite

P. Rothenberg — researcher profile on SciRah

Invite

S. Sha — researcher profile on SciRah

Invite

E. Wajs — researcher profile on SciRah

Invite

C. Curtin — researcher profile on SciRah

Invite

S. Weiner — researcher profile on SciRah

Invite

P. Stein — researcher profile on SciRah

J. Ariyawansa×3

Invite

J. Ariyawansa — researcher profile on SciRah